Hysteroscopic sterilization of patient with intrauterine device Mirena
Tubal sterilization is the definitive procedure most often used worldwide to control fecundity. Laparoscopic ligature is safe, but invasive and with possible surgical and anesthetic risks. The hysteroscopic approach enables tubal occlusion at outpatient's setting without the need of incisions o...
Gespeichert in:
Veröffentlicht in: | Einstein (São Paulo, Brazil) Brazil), 2013-01, Vol.11 (1), p.108-110 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 110 |
---|---|
container_issue | 1 |
container_start_page | 108 |
container_title | Einstein (São Paulo, Brazil) |
container_volume | 11 |
creator | Depes, Daniella De Batista Pereira, Ana Maria Gomes Yatabe, Salete Lopes, Reginaldo Guedes Coelho |
description | Tubal sterilization is the definitive procedure most often used worldwide to control fecundity. Laparoscopic ligature is safe, but invasive and with possible surgical and anesthetic risks. The hysteroscopic approach enables tubal occlusion at outpatient's setting without the need of incisions or anesthesia. A microdevice (Essure®) is inserted directly into the tubes and its polyethelene fibers cause obstruction of tubes in about three months. During this period, it is recommended that patients continue the use of a temporary birth control method. Several women use the levonorgestrel-releasing intrauterine system, which is called in the market as Mirena®. This report evaluated the possibility of inserting Essure® without remove the intrauterine device; patient tolerance to the procedure was also assessed. The tubal device was successfully placed in the patient without the need to remove Mirena®. After three months the intrauterine device was removed with no intercurrent events. |
doi_str_mv | 10.1590/S1679-45082013000100019 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4872978</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1444859220</sourcerecordid><originalsourceid>FETCH-LOGICAL-p266t-1f7bb0068b6a403085bdb6d581db6307c745867a2d147746a2e2df21cbd08193</originalsourceid><addsrcrecordid>eNpVUEtLw0AYXESxtfoXNEcv0X0_LoIUa4WKB3tfNpuNXUmyMZtU6q83wVr08DED3zAzDABXCN4gpuDtK-JCpZRBiSEiEEI0njoCU0yQSDmR7BhMD6IJOIvxHUKOuFSnYIIJE0owMgWL5S52rg3RhsbbZOS-9F-m86FOQpE0A3N1l3z6bpP4umtNP0pql-Ru661Lnn3ranMOTgpTRnexxxlYLx7W82W6enl8mt-v0gZz3qWoEFk21JAZNxQSKFmWZzxnEg1AoLCCMsmFwTmiQlBusMN5gZHNciiRIjNw92Pb9FnlcuvGQqVuWl-ZdqeD8fr_p_Yb_Ra2mkqBlZCDwfXeoA0fvYudrny0rixN7UIfNaKUSqYwhoP08m_WIeR3O_INcqt0Eg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1444859220</pqid></control><display><type>article</type><title>Hysteroscopic sterilization of patient with intrauterine device Mirena</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Depes, Daniella De Batista ; Pereira, Ana Maria Gomes ; Yatabe, Salete ; Lopes, Reginaldo Guedes Coelho</creator><creatorcontrib>Depes, Daniella De Batista ; Pereira, Ana Maria Gomes ; Yatabe, Salete ; Lopes, Reginaldo Guedes Coelho</creatorcontrib><description>Tubal sterilization is the definitive procedure most often used worldwide to control fecundity. Laparoscopic ligature is safe, but invasive and with possible surgical and anesthetic risks. The hysteroscopic approach enables tubal occlusion at outpatient's setting without the need of incisions or anesthesia. A microdevice (Essure®) is inserted directly into the tubes and its polyethelene fibers cause obstruction of tubes in about three months. During this period, it is recommended that patients continue the use of a temporary birth control method. Several women use the levonorgestrel-releasing intrauterine system, which is called in the market as Mirena®. This report evaluated the possibility of inserting Essure® without remove the intrauterine device; patient tolerance to the procedure was also assessed. The tubal device was successfully placed in the patient without the need to remove Mirena®. After three months the intrauterine device was removed with no intercurrent events.</description><identifier>ISSN: 1679-4508</identifier><identifier>EISSN: 2317-6385</identifier><identifier>DOI: 10.1590/S1679-45082013000100019</identifier><identifier>PMID: 23579753</identifier><language>eng</language><publisher>Brazil: Instituto Israelita de Ensino e Pesquisa Albert Einstein</publisher><subject>Adult ; Case Report ; Contraceptive Agents, Female - therapeutic use ; Device Removal ; Female ; Humans ; Hysteroscopy - methods ; Intrauterine Devices ; Levonorgestrel - therapeutic use ; Polyesters - therapeutic use ; Reproducibility of Results ; Sterilization, Tubal - instrumentation ; Sterilization, Tubal - methods ; Treatment Outcome</subject><ispartof>Einstein (São Paulo, Brazil), 2013-01, Vol.11 (1), p.108-110</ispartof><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872978/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872978/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23579753$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Depes, Daniella De Batista</creatorcontrib><creatorcontrib>Pereira, Ana Maria Gomes</creatorcontrib><creatorcontrib>Yatabe, Salete</creatorcontrib><creatorcontrib>Lopes, Reginaldo Guedes Coelho</creatorcontrib><title>Hysteroscopic sterilization of patient with intrauterine device Mirena</title><title>Einstein (São Paulo, Brazil)</title><addtitle>Einstein (Sao Paulo)</addtitle><description>Tubal sterilization is the definitive procedure most often used worldwide to control fecundity. Laparoscopic ligature is safe, but invasive and with possible surgical and anesthetic risks. The hysteroscopic approach enables tubal occlusion at outpatient's setting without the need of incisions or anesthesia. A microdevice (Essure®) is inserted directly into the tubes and its polyethelene fibers cause obstruction of tubes in about three months. During this period, it is recommended that patients continue the use of a temporary birth control method. Several women use the levonorgestrel-releasing intrauterine system, which is called in the market as Mirena®. This report evaluated the possibility of inserting Essure® without remove the intrauterine device; patient tolerance to the procedure was also assessed. The tubal device was successfully placed in the patient without the need to remove Mirena®. After three months the intrauterine device was removed with no intercurrent events.</description><subject>Adult</subject><subject>Case Report</subject><subject>Contraceptive Agents, Female - therapeutic use</subject><subject>Device Removal</subject><subject>Female</subject><subject>Humans</subject><subject>Hysteroscopy - methods</subject><subject>Intrauterine Devices</subject><subject>Levonorgestrel - therapeutic use</subject><subject>Polyesters - therapeutic use</subject><subject>Reproducibility of Results</subject><subject>Sterilization, Tubal - instrumentation</subject><subject>Sterilization, Tubal - methods</subject><subject>Treatment Outcome</subject><issn>1679-4508</issn><issn>2317-6385</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUEtLw0AYXESxtfoXNEcv0X0_LoIUa4WKB3tfNpuNXUmyMZtU6q83wVr08DED3zAzDABXCN4gpuDtK-JCpZRBiSEiEEI0njoCU0yQSDmR7BhMD6IJOIvxHUKOuFSnYIIJE0owMgWL5S52rg3RhsbbZOS-9F-m86FOQpE0A3N1l3z6bpP4umtNP0pql-Ru661Lnn3ranMOTgpTRnexxxlYLx7W82W6enl8mt-v0gZz3qWoEFk21JAZNxQSKFmWZzxnEg1AoLCCMsmFwTmiQlBusMN5gZHNciiRIjNw92Pb9FnlcuvGQqVuWl-ZdqeD8fr_p_Yb_Ra2mkqBlZCDwfXeoA0fvYudrny0rixN7UIfNaKUSqYwhoP08m_WIeR3O_INcqt0Eg</recordid><startdate>201301</startdate><enddate>201301</enddate><creator>Depes, Daniella De Batista</creator><creator>Pereira, Ana Maria Gomes</creator><creator>Yatabe, Salete</creator><creator>Lopes, Reginaldo Guedes Coelho</creator><general>Instituto Israelita de Ensino e Pesquisa Albert Einstein</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201301</creationdate><title>Hysteroscopic sterilization of patient with intrauterine device Mirena</title><author>Depes, Daniella De Batista ; Pereira, Ana Maria Gomes ; Yatabe, Salete ; Lopes, Reginaldo Guedes Coelho</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p266t-1f7bb0068b6a403085bdb6d581db6307c745867a2d147746a2e2df21cbd08193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult</topic><topic>Case Report</topic><topic>Contraceptive Agents, Female - therapeutic use</topic><topic>Device Removal</topic><topic>Female</topic><topic>Humans</topic><topic>Hysteroscopy - methods</topic><topic>Intrauterine Devices</topic><topic>Levonorgestrel - therapeutic use</topic><topic>Polyesters - therapeutic use</topic><topic>Reproducibility of Results</topic><topic>Sterilization, Tubal - instrumentation</topic><topic>Sterilization, Tubal - methods</topic><topic>Treatment Outcome</topic><toplevel>online_resources</toplevel><creatorcontrib>Depes, Daniella De Batista</creatorcontrib><creatorcontrib>Pereira, Ana Maria Gomes</creatorcontrib><creatorcontrib>Yatabe, Salete</creatorcontrib><creatorcontrib>Lopes, Reginaldo Guedes Coelho</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Einstein (São Paulo, Brazil)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Depes, Daniella De Batista</au><au>Pereira, Ana Maria Gomes</au><au>Yatabe, Salete</au><au>Lopes, Reginaldo Guedes Coelho</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hysteroscopic sterilization of patient with intrauterine device Mirena</atitle><jtitle>Einstein (São Paulo, Brazil)</jtitle><addtitle>Einstein (Sao Paulo)</addtitle><date>2013-01</date><risdate>2013</risdate><volume>11</volume><issue>1</issue><spage>108</spage><epage>110</epage><pages>108-110</pages><issn>1679-4508</issn><eissn>2317-6385</eissn><abstract>Tubal sterilization is the definitive procedure most often used worldwide to control fecundity. Laparoscopic ligature is safe, but invasive and with possible surgical and anesthetic risks. The hysteroscopic approach enables tubal occlusion at outpatient's setting without the need of incisions or anesthesia. A microdevice (Essure®) is inserted directly into the tubes and its polyethelene fibers cause obstruction of tubes in about three months. During this period, it is recommended that patients continue the use of a temporary birth control method. Several women use the levonorgestrel-releasing intrauterine system, which is called in the market as Mirena®. This report evaluated the possibility of inserting Essure® without remove the intrauterine device; patient tolerance to the procedure was also assessed. The tubal device was successfully placed in the patient without the need to remove Mirena®. After three months the intrauterine device was removed with no intercurrent events.</abstract><cop>Brazil</cop><pub>Instituto Israelita de Ensino e Pesquisa Albert Einstein</pub><pmid>23579753</pmid><doi>10.1590/S1679-45082013000100019</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1679-4508 |
ispartof | Einstein (São Paulo, Brazil), 2013-01, Vol.11 (1), p.108-110 |
issn | 1679-4508 2317-6385 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4872978 |
source | MEDLINE; DOAJ Directory of Open Access Journals; PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection |
subjects | Adult Case Report Contraceptive Agents, Female - therapeutic use Device Removal Female Humans Hysteroscopy - methods Intrauterine Devices Levonorgestrel - therapeutic use Polyesters - therapeutic use Reproducibility of Results Sterilization, Tubal - instrumentation Sterilization, Tubal - methods Treatment Outcome |
title | Hysteroscopic sterilization of patient with intrauterine device Mirena |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T00%3A48%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hysteroscopic%20sterilization%20of%20patient%20with%20intrauterine%20device%20Mirena&rft.jtitle=Einstein%20(Sa%CC%83o%20Paulo,%20Brazil)&rft.au=Depes,%20Daniella%20De%20Batista&rft.date=2013-01&rft.volume=11&rft.issue=1&rft.spage=108&rft.epage=110&rft.pages=108-110&rft.issn=1679-4508&rft.eissn=2317-6385&rft_id=info:doi/10.1590/S1679-45082013000100019&rft_dat=%3Cproquest_pubme%3E1444859220%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1444859220&rft_id=info:pmid/23579753&rfr_iscdi=true |